There is an Opioid Crisis in the United States.
In March 2016, the CDC recommended a patient receive no greater than 90 daily morphine milligram equivalents (MME) units (Oxycontin 80mg TID has 360 MME, Fentanyl Patch 100ug/3-day has 240 MME and Hydrocodone 75mg TID has 225 MME) and CIGNA announced they will no longer cover Oxycontin. Physicians and pharmacies are reluctant to write/fill prescriptions knowing the DEA is now monitoring MME units and the OIG is investigating over prescribing.
An unintended consequence is 77 million chronic non-cancer sufferers might not receive needed pain relief.
View the following materials to participate in the next generation of chronic pain relief.
1854 Veterans Highway
Levittown, PA 19056
Safer and more effective pain management
Physicians across America are looking for a safe and effective product to help patients cope with long-term, chronic pain. New opioid restrictions have forced physicians to greatly restrict the amount of morphine equivalents they can prescribe. However, as a result, patients are no longer getting the relief that they need. This creates a conundrum for the patient and the physician.
This is why we created the LoMed Program. We believe that pain management should be safe, effective, and in compliance with regulatory standards.
LoMed provides significant pain relief with the absence of withdrawal symptoms, dysphoria, constipation and a significantly reduced risk of overdose.
To enroll today as a certified LoMed provider, please download the enrollment form and fax it to the number on the sheet.
To opt in to participating in the LoMed Certified listing provider page, please complete and submit the following form.